Association Between Ultraprocessed Food Consumption and Cardiovascular Disease Risk (JACC: Advances April 2026)
Description

Background: Ultra-processed foods (UPFs) have been linked to adverse cardiometabolic outcomes and increased atherosclerotic cardiovascular disease (ASCVD) risk. However, prior research has largely focused on homogenous populations, lacking racial and ethnic diversity.

Objective: The objective is to examine the longitudinal relationship between UPF consumption and ASCVD risk and to investigate whether these associations differ by race/ethnicity, sex, or socioeconomic status.

Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective cohort study of 6,814 U.S. adults aged 45-84 years, without clinically apparent CVD. UPF consumption was classified according to the Nova classification system. Multivariable cox proportional hazards models were used to evaluate the association between UPF intake and incident CVD events. Incident hard CVD events included non-fatal myocardial infarction (MI), resuscitated cardiac arrest, death resulting from CHD, stroke (not TIA), and death resulting from stroke.

Results: Each additional daily serving of UPF was associated with a 5.4% increased risk of hard ASCVD events (HR: 1.054; 95% CI: 1.015-1.094). Participants in the highest quintile of UPF consumption had a 66.8% higher risk compared to those in the lowest (HR: 1.668; 95% CI: 1.196-2.325). A significant multiplicative interaction was observed between UPF intake and Black race (p =0.044), with stratified analyses demonstrating a higher ASCVD risk in Black Americans (HR: 1.061; 95% CI: 1.016-1.108), compared to non-Black Americans (HR: 1.032; 95% CI: 1.001-1.065).

Conclusion and Relevance: In a large, multi-ethnic cohort, higher ultra-processed food consumption was significantly associated with an increased risk for ASCVD events, with a more pronounced association among Black Americans.

 

JACC: Advances Editor-in-Chief 

Candice K. Silversides, MD, FACC


JACC: Advances CME Editor

Kenneth A. Ellenbogen, MD


Author

Amier Haidar, MD, MPH

 

Important Dates

Date of Release: April 22, 2026 

Term of Approval/Date of CME/MOC Expiration: March 21, 2027 
Summary
Availability:
On-Demand
Access expires on Apr 21, 2027
Cost:
FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ABP-MOC Point
Android App Download IOS App Download Powered By